Safety & Feasibility of DSR TherApy in Heart FAiluRe pAtients With Persistent Congestion
NCT04882358
·
clinicaltrials.gov ↗
NA
Phase
UNKNOWN
Status
24
Enrollment
INDUSTRY
Sponsor class
Conditions
Heart Failure
Volume Overload
Interventions
DEVICE:
ALFAPUMP DSR (DIRECT SODIUM REMOVAL) SYSTEM
DRUG:
SGLT2 inhibitor
Sponsor
Sequana Medical N.V.